Ralf Kittler to Oncogene Proteins
This is a "connection" page, showing publications Ralf Kittler has written about Oncogene Proteins.
Connection Strength
1.076
-
Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer. Cancer Lett. 2018 12 01; 438:86-96.
Score: 0.621
-
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. Proc Natl Acad Sci U S A. 2014 Mar 18; 111(11):4251-6.
Score: 0.454